Patents by Inventor Tadao Tanouchi
Tadao Tanouchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 4831045Abstract: The rhodanine derivatives of the general formula: ##STR1## [wherein (I) R.sup.1 and R.sup.2 are taken together to represent a tetramethylene or pentamethylene group; (II) R.sup.1 represents a hydrogen atom, and R.sup.Type: GrantFiled: September 10, 1987Date of Patent: May 16, 1989Assignee: Ono Pharmaceutical Co., Ltd.Inventors: Tadao Tanouchi, Masanori Kawamura, Akio Ajima, Tetsuya Mohri, Masaki Hayashi, Hiroshi Terashima, Fumio Hirata, Takeshi Morimura
-
Patent number: 4791126Abstract: The rhodanine derivatives of the general formula: ##STR1## [wherein (I) R.sup.1 and R.sup.2 are taken together to represent a tetramethylene or pentamethylene group; (II) R.sup.1 represents a hydrogen atom, and R.sup.Type: GrantFiled: September 10, 1987Date of Patent: December 13, 1988Assignee: Ono Pharmaceutical Co., Ltd.Inventors: Tadao Tanouchi, Masanori Kawamura, Akio Ajima, Tetsuya Mohri, Masaki Hayashi, Hiroshi Terashima, Fumio Hirata, Takeshi Morimura
-
Patent number: 4464382Abstract: The rhodanine derivatives of the general formula: ##STR1## wherein (I) R.sup.1 and R.sup.2 are taken together to represent a tetramethylene or pentamethylene group; (II) R.sup.1 represents a hydrogen atom, and R.sup.2 represents (1) a cycloalkyl or cycloalkenyl group of 4-7 carbon atoms which is unsubstituted or substituted by at least one alkyl group of 1-4 carbon atoms, (2) an anthryl or naphthyl group, (3) a phenyl group which is unsubstituted or substituted, (4) a heterocyclic group containing at least one of nitrogen, oxygen and sulfur atoms which is unsubstituted or substituted (5) a ##STR2## group (wherein R.sup.4 represents a hydrogen atom, a halogen atom, phenyl group or an alkyl group of 1-5 carbon atoms; and R.sup.5 represents a hydrogen atom, a phenyl group or an alkyl group of 1-5 carbon atoms) or ##STR3## group; or (III) R.sup.1 and R.sup.2, which may be the same or different with each other, each represents a phenyl group which is unsubstituted or substituted; and R.sup.Type: GrantFiled: August 12, 1981Date of Patent: August 7, 1984Assignee: Ono Pharmaceutical Co., Ltd.Inventors: Tadao Tanouchi, Masanori Kawamura, Akio Ajima, Tetsuya Mohri, Masaki Hayashi, Hiroshi Terashima, Fumio Hirata, Takeshi Morimura
-
Patent number: 4446143Abstract: The rhodanine derivatives of the general formula: ##STR1## possess a strong inhibitory activity on aldose reductase, and are useful for the prevention and treatment of nerve disturbances such as neuralgia, retinopathy, diabetic cataract and renal disturbances such as tubular nephropathy.Type: GrantFiled: July 27, 1981Date of Patent: May 1, 1984Assignee: Ono Pharmaceutical Co., Ltd.Inventors: Tadao Tanouchi, Satoshi Shigeoka, Masanori Kawamura, Masaki Hayashi, Hiroshi Terashima, Fumio Hirata
-
Patent number: 4427682Abstract: The pyridine derivatives of the general formula: ##STR1## [wherein A represents an alkylene group containing from 1 to 5 carbon atoms unsubstituted or substituted by a hydroxy group, B represents a single bond, or an oxygen or sulphur atom, or an alkylene group containing from 1 to 5 carbon atoms, D represents a single bond, or an alkylene group containing from 1 to 5 carbon atoms, E represents a grouping of the formula: ##STR2## (in which R.sup.6 represents a hydrogen atoms, or an alkyl group containing from 1 to 4 carbon atoms), Z represents a single bond, or an ethynylene group, or a grouping of the formula: ##STR3## in which R.sup.2 represents a hydrogen atom, or an alkyl group containing from 1 to 4 carbon atoms, R.sup.3 represents a hydrogen, bromine or chlorine atom, or an alkyl group containing from 1 to 4 carbon atoms, the symbol represents a single or double bond, the carbon atom attached to R.sup.2 binds to B, and the carbon atom attached to R.sup.3 binds to D, R.sup.Type: GrantFiled: December 11, 1981Date of Patent: January 24, 1984Assignees: Ono Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd.Inventors: Tadao Tanouchi, Masanori Kawamura, Masaki Havashi
-
Patent number: 4374845Abstract: The imidazole derivatives of the general formula: ##STR1## (wherein R.sup.1 represents a hydrogen atom or straight- or branched-chain alkyl group of 1 to 4 carbon atoms), or pharmaceutically acceptable non-toxic salts thereof, which have a specifically inhibitory effect on the biosynthesis of thromboxane A.sub.2 (abbreviated as TXA.sub.2 hereafter) and are, therefore, useful as treating agents for disease caused by TXA.sub.2 such as inflammation, cerebral apoplexy, miocardial infarction, acute cardiac death, cardiostenosis and thrombus etc.Type: GrantFiled: October 22, 1981Date of Patent: February 22, 1983Assignees: Kissei Pharmaceutical Co., Ono Pharmaceutical Co., Ltd.Inventors: Tadao Tanouchi, Masanori Kawamura, Masaki Hayashi
-
Patent number: 4355170Abstract: The imidazole derivatives of the general formula: ##STR1## wherein R.sup.1 represents a hydrogen atom, or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms, R.sup.2 represents a hydrogen atom, or a straight- or branched-chain alkyl group containing from 1 to 4 carbon atoms, R.sup.3 represents a straight- or branched-chain alkyl group containing from 1 to 10 carbon atoms, and m and n, which may be the same or different, each represent zero, or an integer of 1 to 10, and non-toxic acid addition salts thereof, and, when R.sup.1 represents a hydrogen atom, non-toxic salts thereof, are new compounds. These compounds have a strong inhibitory effect on thromboxane synthetase from rabbit platelet microsomes, and are useful as therapeutically active agents for inflammation, hypertension, thrombus, cerebral apoplexy and asthma.Type: GrantFiled: May 2, 1979Date of Patent: October 19, 1982Assignees: Ono Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd.Inventors: Masaki Hayashi, Tadao Tanouchi, Masanori Kawamura, Yoichi Iguchi
-
Patent number: 4346099Abstract: The imidazole derivatives of the general formula: ##STR1## [wherein m represents an integer of 4 to 9, R.sup.1 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms, and one of R.sup.2 and R.sup.3 represents a hydrogen atom, and the other represents a halogen atom or a phenyl group, or R.sup.2 and R.sup.3 together represent --(CH.sub.2).sub.n --(in which n represents an integer of 4 to 6) or represent .dbd.CH.sub.2 ] and non-toxic salts thereof, which have a specifically inhibitory effect on the biosynthesis of thromboxane A.sub.2 (abbreviated as TXA.sub.2 hereafter) and are, therefore, useful as treating agents for diseases caused by TXA.sub.2 such as inflammation, cerebral apoplexy, myocardial infarction, acute cardiac death, cardiostenosis and thrombus etc.Type: GrantFiled: September 22, 1981Date of Patent: August 24, 1982Assignees: Ono Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd.Inventors: Tadao Tanouchi, Masanori Kawamura, Takanori Okada, Masaki Hayashi
-
Patent number: 4317828Abstract: The pyridine derivatives of the general formula: ##STR1## [wherein A represents an alkylene group containing from 1 to 5 carbon atoms unsubstituted or substituted by a hydroxy group, B represents a single bond, or an oxygen or sulphur atom, or an alkylene group containing from 1 to 5 carbon atoms, D represents a single bond, or an alkylene group containing from 1 to 5 carbon atoms, E represents a grouping of the formula: ##STR2## (in which R.sup.6 represents a hydrogen atom, or an alkyl group containing from 1 to 4 carbon atoms), Z represents a single bond, or an ethynylene group, or a grouping of the formula: ##STR3## in which R.sup.2 represents a hydrogen atom, or an alkyl group containing from 1 to 4 carbon atoms, R.sup.3 represents a hydrogen, bromine or chlorine atom, or an alkyl group containing from 1 to 4 carbon atoms, the symbol represents a single or double bond, the carbon atom attached to R.sup.2 binds to B, and the carbon atom attached to R.sup.3 binds to D, R.sup.Type: GrantFiled: February 12, 1981Date of Patent: March 2, 1982Assignees: Ono Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd.Inventors: Tadao Tanouchi, Masanori Kawamura, Masaki Hayashi
-
Patent number: 4271170Abstract: The pyridine derivatives of the general formula: ##STR1## [wherein A represents an alkylene group containing from 1 to 5 carbon atoms unsubstituted or substituted by a hydroxy group, B represents a single bond, or an oxygen or sulphur atom, or an alkylene group containing from 1 to 5 carbon atoms, D represents a single bond, or an alkylene group containing from 1 to 5 carbon atoms, R represents a grouping of the formula: ##STR2## (in which R.sup.6 represents a hydrogen atom, or an alkyl group containing from 1 to 4 carbon atoms), Z represents a single bond, or an ethynylene group, or a grouping of the formula: ##STR3## in which R.sup.2 represents a hydrogen atom, or an alkyl group containing from 1 to 4 carbon atoms, R.sup.3 represents a hydrogen, bromine or chlorine atom, or an alkyl group containing from 1 to 4 carbom atoms; the symbol represents a single or double bond, the carbon atom attached to R.sup.2 binds to B, and the carbon atom attached to R.sup.3 binds to D, R.sup.Type: GrantFiled: December 20, 1979Date of Patent: June 2, 1981Assignees: Ono Pharmaceutical Co., Ltd.,, Kissei Pharmaceutical Co., Ltd.Inventors: Tadao Tanouchi, Masanori Kawamura, Masaki Hayashi
-
Patent number: 4256757Abstract: The imidazole derivatives of the general formula: ##STR1## wherein R.sup.1 represents a hydrogen atom, or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms, the symbol .dbd. represents a double bond that bond is E or Z, or a triple bond, and m and n, which may be the same or different, each represent zero, or an integer of 1 to 10, and non-toxic acid addition salts thereof, and, when R.sup.1 represents a hydrogen atom, non-toxic salts thereof are new compounds. These compounds have a strong inhibitory effect on thromboxane synthetase from rabbit platelet microsomes, and are useful as therapeutically active agents for inflammation, hypertension, thrombus, cerebral apoplexy and asthma.Type: GrantFiled: May 2, 1979Date of Patent: March 17, 1981Assignees: Ono Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd.Inventors: Masaki Hayashi, Tadao Tanouchi, Masanori Kawamura, Ikuo Kajiwara
-
Patent number: 4066751Abstract: Prostaglandin analogues of the formula: ##STR1## wherein X represents oxygen or sulphur, R.sup.1 and R.sup.2 each represent hydrogen or alkyl of from 1 to 3 carbon atoms, alkenyl of from 2 to 4 carbon atoms or trifluoromethyl, and the double bonds depicted in positions C.sub.5 -C.sub.6 and C.sub.13 -C.sub.14 are cis and trans respectively. These compounds are indicated in the treatment of impaired fertility, induction of labor or termination of pregnancy in females.Type: GrantFiled: October 23, 1975Date of Patent: January 3, 1978Assignee: Ono Pharmaceutical CompanyInventors: Masaki Hayashi, Seiji Kori, Tadao Tanouchi
-
Patent number: 4061865Abstract: Prostaglandin compounds of the formula: ##STR1## wherein A represents a grouping of formula II, III or IV indicated below and (i)R.sub.1 represents an unsubstituted n-butyl, n-pentyl, n-hexyl or n-heptyl radical, or such a radical carrying one, two or three alkyl substituents of 1 to 4 carbon atoms, or R.sub.1 represents a methyl, ethyl, propyl or butyl radical carrying a phenyl, cyclohexyl or cyclopentyl substituent, R.sub.2 represents a hydrogen atom or an alkyl radical of 1 to 4 carbon atoms, and R.sub.3 represents a hydrogen atom, or (ii) R.sub.1 represents n-butyl, or n-butyl or n-pentyl carrying one, two or three alkyl substituents of 1 to 4 carbon atoms, or R.sub.1 represents a methyl, ethyl, propyl or butyl radical carrying a phenyl, cyclohexyl or cyclopentyl substituent, R.sub.2 represents a hydrogen atom or an alkyl radical of 1 to 4 carbon atoms, and R.sub.3 represents an alkyl radical of 1 to 4 carbon atoms are disclosed. These compounds exhibit characteristic prostaglandin-like activity.Type: GrantFiled: August 11, 1975Date of Patent: December 6, 1977Assignee: Ono Pharmaceutical CompanyInventors: Masaki Hayashi, Tadao Tanouchi, Hiroyuki Ito, Isao Ohyama
-
Patent number: 3962312Abstract: Prostaglandin compounds of the formula: ##SPC1##Wherein A represents a grouping of formula II, III or IV indicated below and (i)R.sub.1 represents an unsubstituted n-butyl, n-pentyl, n-hexyl or n-heptyl radical, or such a radical carrying one, two or three alkyl substituents of 1 to 4 carbon atoms, or R.sub.1 represents a methyl, ethyl, propyl or butyl radical carrying a phenyl, cyclohexyl or cyclopentyl substituent, R.sub.2 represents a hydrogen atom or an alkyl radical of 1 to 4 carbon atoms, and R.sub.3 represents a hydrogen atom, or (ii) R.sub.1 represents n-butyl, or n-butyl or n-pentyl carrying one, two or three alkyl substituents of 1 to 4 carbon atoms, or R.sub.1 represents a methyl, ethyl, propyl or butyl radical carrying a phenyl, cyclohexyl or cyclopentyl substituent, R.sub.2 represents a hydrogen atom or an alkyl radical of 1 to 4 carbon atoms, and R.sub.3 represents an alkyl radical of 1 to 4 carbon atoms are disclosed. These compounds exhibit characteristic prostaglandin-like activity.Type: GrantFiled: September 19, 1973Date of Patent: June 8, 1976Assignee: Ono Pharmaceutical CompanyInventors: Masaki Hayashi, Tadao Tanouchi, Hiroyuki Ito, Isao Ohyama